Published 07/01/2024 6:00:55 a.m.

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA - Nyxoah (NASDAQ:NYXH)

Summary by Benzinga

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA Mont-Saint-Guibert (Belgium), July 1, 2024, 8:00am CET / 2:00am ET – ("Nyxoah" or the "Company"), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company submitted the fourth and final module of its Premarket Approval (PMA) application for Genio to…

0 Articles

All

Left

Center

Right

Benzinga

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA - Nyxoah (NASDAQ:NYXH)

07/01/2024 2:00:00 a.m.·New York, United States

Read Full Article

Financial Post

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA

“I am proud to achieve this important milestone, which brings us one step closer to offering Genio to obstructive sleep apnea patients in the U.S. I would like to congratulate our entire team on their hard work in completing the PMA submission. I could not be more excited for the remainder of 2024, which includes presenting the complete DREAM data at the International Surgical Sleep Society meeting in September and preparing for a U.S. launch by…

07/01/2024 6:00:55 a.m.·Canada

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources0

Leaning Left0Leaning Right1Center1Last Updated07/01/2024 9:08:08 a.m.Bias Distribution

50% Center, 50% Right

Bias Distribution

50% of the sources are Center, 50% of the sources lean Right

50% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA - Nyxoah (NASDAQ:NYXH)

0 Articles

0 Articles

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA - Nyxoah (NASDAQ:NYXH)

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA - Nyxoah (NASDAQ:NYXH)

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics